• Muhammad Irfan Qadir
  • Mohammad Tahir
  • Khalid P Lone
  • Bushra Munir
  • Waqas Sami


Background: Use of gentamicin is now limited due to its toxic effects, mainly on kidney andvestibular system. Herbal products including ginseng has been reported to possess protective effectsagainst drugs induced nephrotoxicity in experimental animals. The current investigation wasdesigned to evaluate the effects of ginseng on gentamicin induced nephrotoxicity. Methods:Eighteen male albino mice of 6–8 weeks age, were divided into 3 groups. Group-A served as controland was given normal mouse diet; Group-B was given 80 mg/Kg/day of gentamicin intraperitoneallydissolved in 1 ml of distilled water for fifteen days. Group-C was given 80 mg/Kg/day of gentamicinintraperitoneally dissolved in 1 ml of distilled water along with 100 mg/Kg/day of ginseng orallydissolved in 1 ml of distilled water, also for fifteen days. At the end of the experiment, blood wasdrawn from each animal by cardiac puncture for renal function tests. Each animal was then sacrificedand kidneys removed for routine histological studies. Results: In group B, weight of the animals andkidneys decreased and there was significant increase in mean serum urea, creatinine andintraluminal diameter (p<0.001) of proximal convoluted tubules as compared to the controls (groupA). Moderate to severe necrotic and degenerative changes in proximal convoluted tubules were seenin this group. When the Ginseng and gentamicin were given together (group-C), a statisticallysignificant improvement in the mean body and kidney weight along with improvement in renalfunction tests and tubular diameter were seen (p<0.001). Conclusion: It appears that Ginseng hassome protective role against gentamicin induced nephrotoxicity.Keywords: Gentamicin, ginseng, nephroprotective role, nephrotoxicity, serum urea, serumcreatinine


Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and

toxicity of single daily dosing versus multiple daily dosing of

aminoglycosides. Clin Infect Dis 1997;24:796–809.

Humes DH, Weinberg JM, Knauss TC. Clinical and

pathophysiologic aspects of aminoglycoside nephrotoxicity.

Am J Kidney Dis 1982;2(1):5–29.

Just M, Erdmann G, Habermann E. The renal handling of

polybasic drugs. Gentamicin and aprotinin in intact animals.

Arch Pharmacol 1977;300(1):57–66.

Sundin DP, Sandoval R, Molitoris BA. Gentamicin inhibits

renal protein and phospholipid metabolism in rats:

Implications involving intracellular trafficking. J Am Soc

Nephrol 2001;12:114–23.

Shah SV, Walker PD. Reactive oxygen metabolites in toxic

acute renal failure. Ren Fail 1992;14:363–70.

Priuska EM, Schacht J. Formation of free radical by

gentamicin and iron and evidence for an iron gentamicin

complex. Biochem Pharmacol 1995;50:1749–52.

Kang KS, Kim HY, Yamabe N, Nagai R, Yokozawa T.

Protective effect of sun ginseng against diabetic renal

damage. Biol Pharm Bull 2006;29:1678–84.

Liu RJ, Wang S, Liu H, Yang L, Nan G. Stimulatory effect of

saponin from Panax ginseng on immune function of lymphocytes

in the elderly. Mech Ageing Dev 1995;83(1):43–53.

Tran QL, Adnyana, IL, Tesuka Y, Saiki I, Kurashigo Y,

Tran QK, et al. Hepatoprotective affect of ginsenoside R2 the

major saponin from Vietnamese ginseng (Panax

Vietnamenesis). Planta Med 2002;68:405–6.

Lee HC, Hwang SG, Lee YG, Sohn HO, Lee DW, Hwang

SY, et al. In vivo effects of panax ginseng extracts on the

cytochrome P450 dependent monooxygenase system in the

liver of 2,3,7,8 tetrachlorodibenzo-p-dioxin exposed guinea

pig. Life Sci 2002;71:957–69.

Nishino H, Tokuda H, Ii T, Takemura M, Kuchide

M, Kanazawa M, et al. Cancer chemoprevention by ginseng

in mouse liver and other organ. J Korean Med Sci


Cooper K, Bennett WM. Nephrotoxicity of common drugs used

in clinical practice. Arch Intern Med 1987;147:1213–8.

Yokozawa T, Zhou JJ, Hattori M, Inaba S, Okada T, Oura H.

Effects of ginseng in nephrectomized rats. Biol Pharm Bull


Chen X, Gillis CN, Moalli R. Vascular effects of

ginsenosides in vitro. Br J Pharmacol 1984;82:485–91.

Ali BH, Abdel Gayoum AA, Bashir AA. Gentamicin

nephrotoxicity in rat: some biochemical correlates.

Pharmacol Toxicol 1992;70:419–23.

Lipsky JJ, Cheng L, Sacktor B, Leitman PS. Gentamicin

uptake by renal brush border membrane vesicles. J Pharm

Clin Ther 1980;215:390–3.

Kacew S. Inability of nitrendipine to protect against

gentamicin nephrotoxicity in rats. Biomed Environ Sci


J Ayub Med Coll Abbottabad 2011;23(4) 57

Morsy FA. Protective effect of ginseng against toxic effects

of ochratoxin in kidney of male rats. Egypt Hosp Med


Morsy FA. Protective effect of vitamin c and ginseng on

experimental liver and kidney injuries induced by insecticide

profenophos in male rats. Egypt J Hosp Med 2003;10:34–51.

Kosek JC, Mazze, RI, Cousions MJ. Nephrotoxicity of

gentamicin. J Lab Invest 1974;30(1):48–57.

Parlakpinar H, Koc M, Polat, Vardi N, Ozer M, Turkoz Y, et

al. Protective effect of aminoguanidine against

nephrotoxicity induced by amikacin in rats. Urol Res


Baliga R, Ueda N, Walker PD, Shah SV. Oxidant

mechanisms in toxic acute renal failure. Drug Metab Rev


Sung H, Kang SM, Lee MS, Kim TG, Cho YK. Korean red

ginseng slows depletion of CD4 T cells in human

immunodeficiency virus type 1 infected patients. Clin Diag

Lab Immunol 2005;22:497–501.

Hattori T, Ito M, Suzuki Y. Studies on antinephritic effects of

plant components in rats and effect of ginsenosides on

original type anti GBM nephritis in rats and its mechanisims.

Folia Pharamacol 1991;97:127–34.

Carabin IG, George A Burdock GA, Chris Chatzidakis C.

Safety assessment of Panax ginseng. Int J Toxicol


Zhang Y. [Protective effects of ginsenosides on warm

ischemic damages of the rabbit kidney]. Zhonghua Yi Xue

Za Zhi 1992;72(2):84–5, 127–8. [Article in Chinese]

Nakajima T, HIShida A, Kato A. Mechanisms for protective

effects of free radical scavengers on gentamicin mediated

nephrotoxicity in rats. Am J Physiol 1994;266(3 part